Received Jul 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | e2jx7 | — |
Kinrix administered to a patient younger than 4 years of age; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old female patient who received DTPa-IPV (Kinrix) suspension for injection in pre-filled syringe (batch number e2jx7 with expiry date 08-OCT-2027) for prophylaxis. On 30-JUN-2026, the patient received Kinrix. On 30-JUN-2026, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix administered to a patient younger than 4 years of age). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JUN-2026 Reporter stated that Kinrix administered to a patient younger than 4 years of age and wanted to know if they need to revaccinate for Dtap.